Back to bills
Maintaining Investments in New Innovation Act
Last updated: 2/27/2025 · Introduced: 2/27/2025
Author: Donald Davis (D-NC)
TL;DR (AI)
- The bill extends the exclusivity period for 'Qualifying Single Source Drugs' to 11 years.
- It defines 'advanced drug product' as a drug utilizing genetically targeted technology that modulates gene function.
- The bill aims to protect access to genetically targeted technologies by amending title XI of the Social Security Act.
Verified Votes
No verified votes yet.
Community Votes
No community votes yet. Be the first!
Voting as guest · Sign in for verified votes
Other Sections
Includes provisions on preamble, short title., and 1 more.
3 sections
Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.
Want the full experience?
Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.
Create Free Account